Welcome back to Health Unlocked! In this episode, we dive into groundbreaking developments in wound care with Jasen Petersen, who recently attended the Symposium of Advanced Wound Care Conference in Charlotte, North Carolina. Jasen shares his experience presenting compelling clinical data on a novel topical ionic cofactor gel for chronic wounds - data so impressive that it met skepticism from the clinical community. We discuss the challenges of clinical trial design, biases in wound care research, and the hurdles of bringing innovative therapies to market, especially as a nonprofit. Jasen also gives us a glimpse into upcoming research, regulatory roadblocks, and how unconventional paths like decentralized science and industry collaboration might unlock better care for patients with chronic wounds. Stay tuned as we explore the realities, hopes, and frustrations behind changing the status quo in healthcare innovation.

Timestamps:

00:00 Talking about the conference experience

05:54 Discussing survivor bias in data

08:23 Conducting a prospective study in Mexico

10:04 Wound healing innovation conference

15:45 Using pig ECM for wound healing

19:04 Discussion on clinical trial criteria

20:10 Limitations of retrospective studies

25:43 Deciding on data collection strategy

27:19 Facing funding study challenges

30:58 Navigating US device approval

34:56 Personal experiences with a remedy

38:12 Discussing the pricing of hydrogel

41:18 Discussing KM analysis for wound closure

45:12 Building the Ionic Alliance Foundation

47:22 Product efficacy and user feedback

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked: The Power of Salutogenesis, where we explore cutting-edge ideas shaping the future of healthcare. In this episode, Jasen Petersen discusses how Ion Biotechnology is pivoting its US market entry strategy amidst shifting crypto and DeSci (Decentralized Science) market conditions.

Instead of pursuing the costly and complex 510k regulatory pathway immediately, he reveals a new plan centered on launching the Ion Gel as a Class 1 medical device or even as a cosmetic product, leveraging the terrain support concept. This approach not only allows faster access to the US market and clinical data generation but also provides a foundation for stronger future regulatory submissions. Along the way, he covers the importance of academic publication, community involvement via token funding, and maintaining transparency as the project evolves.

Tune in to get a real-time look at how innovation, regulation, and community engagement intersect in biotech.

Timestamps:

00:00 Finding a cost-effective FDA strategy

06:17 FDA classification and product function

09:33 Understanding product claims and regulations

12:51 Preventing diabetic foot ulcers

17:15 Overview of the research papers

21:30 Launching token before DAO

24:50 Presenting research and generating interest

27:22 FDA reclassification and strategy

31:37 Using real-world data for strategy

35:26 Navigating FDA classification challenges

38:09 Connecting with Jason and updates

39:50 Wrapping up the episode

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked! In this episode, Jasen Petersen dives into a topic that’s often underestimated in both startups and massive institutions: why good intentions just aren’t enough to drive lasting, positive change, especially in healthcare. You’ll hear how structural forces, capital pressures, and the limits of traditional governance repeatedly overpower even the most mission-driven organizations.

Using real-world examples, from the century-long journey of insulin to the rise of tech behemoths like Google, Jasen Petersen explains how systems, not simply personalities or promises, determine outcomes. He breaks down what goes wrong when intentions meet reality, and why scaling up almost always means values get tested to the breaking point.

Then, the conversation takes a fascinating turn toward solutions: exploring how decentralized science (DeSci), token-based governance, and transparent incentive structures could reshape who holds power and how decisions get made in healthcare innovation. You’ll hear exactly how Jasen Petersen is building new governance models to make sure that, this time, the “right thing” isn’t just a slogan, it’s built into the DNA of the system itself.

If you’re interested in the intersections of health, technology, economics, and mission-driven innovation, this episode is for you. Let’s get started!

Timestamps:

00:00 "Good Intentions vs. Systemic Pressures"

05:32 "Startup Governance and Capital Evolution"

08:02 "Healthcare's Free Market Misconception"

11:28 Aligned Incentives Drive Ethical Governance

14:51 "Structural Issues in Healthcare"

18:41 Decentralized IP Licensing Framework

20:58 "Impact of Poor IP Governance"

23:47 "Collaborative Data Strengthens Outcomes"

29:25 "Interconnected Innovation Strengthens IP Strategy"

33:09 "Mouthwash Innovation Through DSi"

34:11 "Decisions by Community Wisdom"

39:10 "DeSci Platform Governance Explained"

43:05 "Challenges of Broad Technology Applications"

44:07 "Structurally Durable Innovation Model"

47:50 "Ion Gel Project Updates"

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/